This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LONDON, Dec. 13, 2012 /PRNewswire/ -- Frost & Sullivan has supported the initial public offering of MD Medical Group (MDMG) on the London Stock Exchange (LSE) in the largest European IPO in the healthcare service space this year.
Earlier, Frost & Sullivan assisted IHH Healthcare with its
US$2 billion IPO – the fourth largest IPO globally in 2012, in
Kuala Lumpur. Additionally, Frost & Sullivan supported the Malaysian palm oil producer, Felda Global Ventures (
US$3.2 billion), the third largest IPO this year, after Facebook and Japan Airlines.
MD Medical Group (MDMG) operates in the highly attractive Russian private healthcare service market, and has a leading position in high-quality women's health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in
St. Petersburg, Ufa and Perm. Also, MDMG operates two franchised outpatient clinics operate in
Kyiv and one in Irkutsk.
US$ 289 million in the IPO which valued the company at
US$ 901 million. Deutsche Bank and JP Morgan acted as Joint Global Coordinators and Joint Book Runners in connection with the transaction.
Commenting on the announcement,
Vitaly Ustimenko, CFO at MDMG, said: "We are the first Russian healthcare services company to attract financing on the London Stock Exchange. Proceeds of the offering will be used to further expand our operations and to finance the construction of the new hospital in Ufa. We had a very positive experience in working with Frost & Sullivan. I would like to particularly highlight their sound commercial analysis and an extremely professional, responsive, and committed team."
Andrew Calvert, Director of Frost & Sullivan's Financial Services practice, said: "MDMG is a great company and was well received by the investment community. I am delighted that we were able to support MDMG in its IPO and am bullish about the company's ability to continue to capitalise on the market dynamics which have contributed to its success. Growth in disposable income, further government support and increasing demand for quality healthcare create the macro conditions in which ambitious, organised and dynamic companies such as MDMG can succeed."
Jaime Martinez, a Consultant in Frost & Sullivan's Financial Services practice, added: "We are confident that MDMG will expand its presence in the women and child healthcare segments, which are amongst the fastest growing in the Russian healthcare services system. The ability to leverage the combined IPO and healthcare services expertise of our Financial Services and Healthcare practices as well as our local presence and expertise in
Moscow was key. It was a pleasure to work with MDMG and its advisors throughout the process."
To find out more about Frost & Sullivan's
Initial Public Offering (IPO) Services, please send an email with your contact details to
Anna Zanchi, Corporate Communications, at
email@example.comAbout Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.